HuGE Literature Finder
Records
1
-
3
Clinical benefit of ixazomib plus lenalidomide-dexamethasone in myeloma patients with non-canonical NF-?B pathway activation. European journal of haematology 2020 5 105 (3): 274-285. Dash Ajeeta B, Zhang Jacob, Shen Lei, Li Bin, Berg Deborah, Lin Jianchang, Avet-Loiseau Hervé, Bahlis Nizar J, Moreau Philippe, Richardson Paul G, Di Bacco Alessand |
Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. Leukemia 2018 01 32 (1): 102-110. Shah V, Sherborne A L, Walker B A, Johnson D C, Boyle E M, Ellis S, Begum D B, Proszek P Z, Jones J R, Pawlyn C, Savola S, Jenner M W, Drayson M T, Owen R G, Houlston R S, Cairns D A, Gregory W M, Cook G, Davies F E, Jackson G H, Morgan G J, Kaiser M |
Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience. BioMed research international 2014 2014 209670. Smetana Jan, Frohlich Jan, Zaoralova Romana, Vallova Vladimira, Greslikova Henrieta, Kupska Renata, Nemec Pavel, Mikulasova Aneta, Almasi Martina, Pour Ludek, Adam Zdenek, Sandecka Viera, Zahradová Lenka, Hajek Roman, Kuglik Pe |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: